Preintervention imaging and intraoperative management care of the hypertrophic obstructive cardiomyopathy patient

Jacobo Moreno Garijo1, Cristina Ibáñez2, Juan M Perdomo2

  • 1Department of Anesthesia and Pain Management, 33540Toronto General Hospital, University of Toronto, Toronto, Canada.

Insights

Hypertrophic cardiomyopathy (HCM) surgery requires careful perioperative management. Transesophageal echocardiography guides assessment and monitoring to optimize outcomes for patients with this common genetic heart condition.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy, with low annual mortality.
  • Surgical septal myectomy is a standard treatment for symptomatic obstructive HCM.
  • Intraoperative transesophageal echocardiography (TEE) is crucial for surgical planning, monitoring, and assessment.

Purpose of the Study:

  • To review the perioperative assessment and management strategies for patients undergoing surgery for hypertrophic obstructive cardiomyopathy.
  • To highlight the challenges posed by dynamic hemodynamic changes during surgical septal myectomy.

Main Methods:

  • This review synthesizes current literature on perioperative care for HCM surgery.
  • It focuses on the role of transesophageal echocardiography in guiding management.
  • Key considerations include hemodynamic stability, rhythm control, and pharmacologic support.

Main Results:

  • Dynamic changes in preload, afterload, and sympathetic tone can affect left ventricle outflow tract (LVOT) obstruction during surgery.
  • Maintaining sinus rhythm, appropriate heart rate, and avoiding hypotension are critical.
  • TEE provides real-time assessment of LVOT gradient and mitral valve motion.

Conclusions:

  • Effective perioperative management of HCM surgery necessitates a thorough understanding of hemodynamic principles.
  • Optimizing preload, afterload, and heart rate, alongside rhythm control, is essential to minimize LVOT obstruction.
  • TEE is indispensable for intraoperative decision-making and post-repair evaluation.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
59
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
117
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53